Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
Titel:
Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
Auteur:
Huang, Yen-Hsiang Hsu, Kuo-Hsuan Tseng, Jeng-Sen Yang, Tsung-Ying Chen, Kun-Chieh Su, Kang-Yi Yu, Sung-Liang Chen, Jeremy J. W. Chang, Gee-Chen